Efavirenz, lamivudine, and tenofovir and Ranibizumab ophthalmic
Determining the interaction of Efavirenz, lamivudine, and tenofovir and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: efavirenz / lamivudine / tenofovir
Brand name: Symfi, Symfi Lo
Synonyms: Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Efavirenz, lamivudine, and tenofovir-Ranitidine
- Efavirenz, lamivudine, and tenofovir-Ranitidine Capsule
- Efavirenz, lamivudine, and tenofovir-Ranitidine Hydrochloride
- Efavirenz, lamivudine, and tenofovir-Ranitidine Injection
- Efavirenz, lamivudine, and tenofovir-Ranitidine Suspension
- Efavirenz, lamivudine, and tenofovir-Ranitidine Syrup
- Ranibizumab ophthalmic-Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate
- Ranibizumab ophthalmic-Effaclor Duo
- Ranibizumab ophthalmic-Effer-K
- Ranibizumab ophthalmic-Effer-K Tablets
- Ranibizumab ophthalmic-Effervescent Potassium
- Ranibizumab ophthalmic-Effervescent Potassium/Chloride